Side by side: size, value over time, results, valuation, margins, growth, debt and shareholder returns, and any of thirty figures charted over the years (up to 6).
Open these as a peer group: up to 12 companies with suggested peers, each company's rank in the group and percentile in its sector and country, saved for you or your team.
From Jan 2020: how each company's value moved, whatever its size.
US$ billions, as reported in each year's annual results.
Revenue of the fiscal year. US dollars at each year's exchange rate.
| Measure | Phreesia, Inc.✕ PHR · #10,647 in the world | Simulations Plus, Inc.✕ SLP |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Healthcare Information Services | Healthcare Information Services |
| Founded | 2005 | 1996 |
| Size | ||
| Market cap | ||
The largest companies, each against its nearest peers in value from the same industry.
| Fiscal year | Phreesia, Inc. | Simulations Plus, Inc. |
|---|---|---|
| 2025 | $481 MSEC | $79 MSEC |
| 2024 | $420 MSEC | $70 MSEC |
| 2023 | $356 MSEC | $60 MSEC |
| 2022 | $281 MSEC | $54 MSEC |
| 2021 | $213 MSEC | $46 MSEC |
| 2020 | $149 MSEC | $42 MSEC |
| 2019 | $125 MSEC | $34 MSEC |
| 2018 | $100 MSEC | $30 MSEC |
| 2017 | $80 MSEC | $24 MSEC |
| 2016 | — | $20 MSEC |
| 2015 | — | $18 MSEC |
| 2014 | — | $11 MSEC |
Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports; Ed. = the company's report (editors); WD = Wikidata, citing the annual report; Cap = value.today market caps. Hover a figure for its period.
| $759 M |
| $371 M* |
| Revenue | $481 M | $79 M |
|---|
| Net income | $2 M▲ best | $-65 M |
|---|
| Employees | 827 | — |
|---|
| Valuation | ||
|---|---|---|
| P/E ratio | 72.6× | — |
| Price to sales | 1.5× | — |
| Price to book | 2.3× | — |
| Free cash flow yield | 8.9% | — |
| Profitability | ||
|---|---|---|
| Gross margin | — | 58.4% |
| Operating margin | -1.4%▲ best | -89.3% |
| Net margin | 0.5%▲ best | -81.7% |
| Return on equity | 0.8%▲ best | -42.1% |
| Growth | ||
|---|---|---|
| Revenue growth | 14.5%▲ best | 13.1% |
| Revenue growth, 3 years a year | 19.6%▲ best | 13.7% |
| Financial strength | ||
|---|---|---|
| Debt to equity | 0.0× | — |
| Net debt to EBITDA | -2.9× | — |
| Cash | ||
|---|---|---|
| Free cash flow margin | 14.1% | 22.0%▲ best |
| Altman Z-score zone | distress | — |
|---|
| Data as of | Market cap Aug 2026; ratios FY2025 | Market cap Aug 2026; ratios FY2025 |
|---|
Market caps from exchange data or SEC filings on the date shown (* last known value, no current one); revenue and net income from the latest annual results; ratios worked out from each company's own statements for the fiscal year shown. ▲ marks the best of these companies where higher or lower is better; size and valuation multiples are marked for no one. Definitions: methodology.